These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2174820)

  • 1. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.
    Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T; Maeda H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Targeting cancer chemotherapy used Lipiodol as a carrier].
    Konno T
    Nihon Rinsho; 1989 Jun; 47(6):1384-90. PubMed ID: 2549286
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
    Konno T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y; Nakamura H
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call(®)) in patients with unresectable hepatocellular carcinoma.
    Yamashita Y; Taketomi A; Itoh S; Harimoto N; Morita K; Fukuhara T; Ueda S; Sanefuji K; Sugimachi K; Tajima T; Maehara Y
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):301-7. PubMed ID: 19495755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
    Ohtsuka N; Konno T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipiodolization prolongs survival rates in postoperative patients with a recurrent hepatocellular carcinoma.
    Furuta T; Kanematsu T; Matsumata T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):494-7. PubMed ID: 2174829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier].
    Konno T; Oda T; Nagamitsu A; Tabaru K; Yamashita R; Kai Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1392-9. PubMed ID: 8854762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eight cases of non-resectable hepatocellular carcinoma surviving for more than 3 years after Lipiodol administration].
    Shirabe K; Kanematsu T; Utsunomiya T; Furuta T; Yamagata M; Matsumata T; Sugimachi K; Yasumori K; Masuda K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2974-7. PubMed ID: 2551238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective effects of Lipiodolized antitumor agents.
    Kanematsu T; Inokuchi K; Sugimachi K; Furuta T; Sonoda T; Tamura S; Hasuo K
    J Surg Oncol; 1984 Mar; 25(3):218-26. PubMed ID: 6199624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
    Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative randomized trial of intermittent intrahepatic arterial carboplatin- versus doxorubicin-lipiodol emulsion in advanced hepatocellular carcinoma (stage IV).
    Homma H; Mezawa S; Doi T; Miyanishi K; Takada K; Kukitsu T; Oku T; Masuko E; Nojiri S; Niitsu Y
    Hepatogastroenterology; 2004; 51(58):1135-9. PubMed ID: 15239261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
    Ikeda K; Saitoh S; Kumada H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeting anticancer chemotherapy dispersed in lipid contrast medium in hepatoblastoma in childhood].
    Ohnuma N; Takahashi H; Tanabe M; Yoshida H; Iwakawa M; Kuriyama Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):788-92. PubMed ID: 2164551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra-arterial infusion chemotherapy of cisplatin (CDDP)-lipiodol suspension using implantable injection port for unresectable liver cancer patients].
    Aogi K; Sawamura A; Funakoshi M; Toge T
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1485-8. PubMed ID: 7690535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.